Systemic Light Chain Amyloidosis Clinical Trials

5 clinical trials for Systemic Light Chain Amyloidosis across international registries, including 4 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• BCMA/CD3 Bispecific Antibody Treatment for Newly Diagnosed Amyloidosis — RECRUITING · PHASE2
• Autologous BCMA-targeted CAR-T Cell Injection for Relapsed/Refractory Light Chain Amyloidosis — RECRUITING · PHASE1
• Assessment of the Efficacy and Safety of Injectable TQB2934 (Subcutaneous Injection) in Systemic Light Chain Amyloidosis Patients — RECRUITING · PHASE1
• The Impact of Systemic Light Chain Amyloidosis on Eyes — RECRUITING
• A Safety Study of Carfilzomib in Patients With Previously-Treated Systemic Light Chain Amyloidosis — COMPLETED · PHASE1

Refine this search